Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin ER with Hypocaloric Diet for Weight Loss in Overweight/Obese Patients
NCT05949008Phase 4Active, not recruiting
- Sponsor
- University of California, Los Angeles
- Start
- Nov 2023
- Primary completion
- Oct 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of liquid metformin (Aspargo Labs) in obesity, sponsored by University of California, Los Angeles. Started Nov 2023; status: active, not recruiting.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
obesity
Beyond the preview
Go deeper on NCT05949008.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05949008.